Bacillus Calmette-Guérin (BCG) is a puny cousin of the bacteria that causes tuberculosis, and as such serves as an excellent vaccine against the disease. But BCG is also used to treat bladder cancer.

Bladder cancer occurs when cells in the bladder — a water balloon–like organ in the lower abdomen that stores urine — grow out of control. There are many treatment options for bladder cancer ...

Bacille Calmette-Guérin (BCG), an attenuated strain of Mycobacterium bovis, is widely administered as a vaccine for tuberculosis. BCG is also used as a biotherapy for superficial bladder carcinoma.

The research, published in the Journal of Clinical Oncology, found the average time to treatment for serious muscle-invasive bladder cancer fell from 98 days to 53 days. Prof Bryan estimates the ...

bladder cancer had significantly less risk of cancer progressing or returning when treated with durvalumab, and were more likely to still be alive two years after treatment. Experts from the ...

Study co-lead investigator Dr James Catto, professor of urology at Sheffield and honorary consultant urological surgeon, said: “This is a major breakthrough in the treatment of bladder cancer.

The various treatment options available ... the BCG vaccine was being used in bladder cancer patients." Martínez-López ...

Each session usually takes three hours, and the full treatment runs for 24 months. Global cancer statistics show that Singapore has one of the highest prevalence of bladder cancer in South-east ...

Using multiparametric MRI (mpMRI) before surgery reduced time to correct treatment by 45 days for patients with muscle invasive bladder cancer. The imaging procedure was successful for over 92% of ...